PHARMACEUTICALS: Provides relative to opioid alternatives. (8/1/24) (EN NO IMPACT See Note)

SB 224 is a procedural bill that amends the text of another legislation concerning opioid alternatives without adding new policies or funding. The bill makes specific technical changes to the language, such as altering how the responsible agency performs its functions and expanding the list of entities it can collaborate with. Because it only modifies existing wording and removes certain sections, it does not create new rules or directly affect the public. The bill was recalled from committee and is currently awaiting further action by the Committee on Finance.